ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1b/2 clinical trial results using CD73 as a potential predictive biomarker

Zhou, Qing; Wu, Lin; Jiang, Bo; Du, Yingying; Wang, Buhai; Hu, Xiaohua; He, Yong; Zhao, Mingfang; Yao, Yu; Cui, Jiuwei; Dong, Xiaorong; Zhang, Haibo; Ma, Rui; Wang, Huijuan; Zhang, Jian; Xia, Jinjing; Zhang, Yanni; Hayslip, John W.; Zhu, Andrew X.; Wu, Yi-Long复旦大学; 广东省人民医院; 安徽医科大学; 华中科技大学; 吉林大学; 南方医科大学; 郑州大学; 西安交通大学; 中国医科大学; 1; i
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2023-6-1
11阅读
引用收藏
分享
相关
加载中…
  • Final overall survival and biomarker analyses of CHOICE-01: A double-blind randomized phase 3 study of toripalimab versus placebo in combination chemotherapy for advanced NSCLC without EGFR/ALK mutations
    Wang, Jie; Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, XiaoliAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • Final progression-free survival, interim overall survival, and biomarker analyses of CHOICE-01: A phase 3 study of toripalimab versus placebo in combination with first-line chemotherapy for advanced NSCLC without EGFR/ALK mutations.
    Wang, Jie; Wang, Zhijie; Wu, Lin; Li, Baolan; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, XiaoliAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
  • Phase I/II combination study of tifcemalimab with toripalimab in patients with refractory extensive stage small cell lung cancer (ES-SCLC)
    Cheng, Ying; Wang, Jie; Yu, Yan; Wang, Qiming; Yang, Runxiang; Lv, Dongqing; Xia, Bing; Yi, Tienan; Li, Chong; Wang, Xicheng; Zhang, Wei; Han, Liang; Liu, Xiaoqing; Shen, Minjie; Xu, Jing; Xue, Peng; Wang, WeihuaAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2023-06-02 至 2023-06-06
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2023-06-01
资助标注
I-Mab Biopharma
收录
ISTP

作者

  • Z

    Zhou, Qing (第一作者)

  • W

    Wu, Lin

查看全部 20 位作者收起作者
  • J

    Jiang, Bo

  • D

    Du, Yingying

  • W

    Wang, Buhai

  • H

    Hu, Xiaohua

  • H

    He, Yong

  • Z

    Zhao, Mingfang

  • Y

    Yao, Yu

  • C

    Cui, Jiuwei

  • D

    Dong, Xiaorong

  • Z

    Zhang, Haibo

  • M

    Ma, Rui

  • W

    Wang, Huijuan

  • Z

    Zhang, Jian

  • X

    Xia, Jinjing

  • Z

    Zhang, Yanni

  • H

    Hayslip, John W.

  • Z

    Zhu, Andrew X.

  • W

    Wu, Yi-Long

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417